Authors: | Richardson, P. G.; Mateos, M. V.; Oriol, A.; Larocca, A.; Cavo, M.; Rodríguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Puig, N.; Zamagni, E.; Thuresson, M.; Harmenberg, J.; Harlin, O.; Blade, J. |
Abstract Title: | HORIZON (OP-106): Melflufen plus dexamethasone in 55 patients with relapsed/refractory multiple myeloma (RRMM) with extramedullary disease (EMD): Subgroup analysis |
Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
Keywords: | myeloma; multiple; mm; extramedullary disease; melflufen; melphalan flufenamide; peptide-drug conjugate |
Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
Volume: | 21 |
Issue: | Suppl. 1 |
Meeting Dates: | 2021 Sep 8-11 |
Meeting Location: | Virtual event |
ISSN: | 2152-2650 |
Publisher: | Elsevier Inc. |
Date Published: | 2021-09-01 |
Start Page: | S427 |
Language: | English |
ACCESSION: | WOS:000691910500391 |
PROVIDER: | wos |
DOI: | 10.1016/s2152-2650(21)01953-4 |
Notes: | Meeting Abstract: MM-186 -- Source: Wos |